F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure medications were properly stored in
accordance with facility ' s policies and procedures and standards of practice when one of three residents,
Resident 3 was observed to have these medications stored at his bedside unlocked:
1. One opened bottle of Genvoya (used to treat infections).
2. An injection pen of Ozempic (used to treat diabetes).
This failure had the potential to place Resident 3 ' s health at risk for drug abuse and ingestion of
unsanitary drugs.
Findings:
During a review of Resident 3 ' s admission Records, the record (contains demographic and medical
information), indicated Resident 3 was admitted on [DATE]. With diagnoses that included type 2 diabetes
mellitus (a disease of not able to control the blood sugar levels), cirrhosis of liver (a condition of damaged
liver) and chronic kidney disease (a condition when the kidneys gradually stop working).
During a review of Resident 3 ' s clinical record, History and Physical dated August 7, 2023, indicated, .
Assessment: . 7. HIV (human immunodeficiency viruses (a disease that destroys the cells that fight infection
in the body) positive Z21 .
During an observation and interview on September 11, 2024, at 9:40 AM, with Resident 3, Resident 3
stated, I keep the medicines here with me (Resident 3 reached for a plastic bag lying on his bed took out a
bottle of Genvoya and an injection per of Ozempic). He stated, I keep them here (pointing at the bed) with
me.
During an interview on September 11, 2024, at 9:50 AM, with Licensed Vocational Nurse (LVN 1), the LVN
1 was asked if Resident 3 kept his medications by the bedside. The LVN 1 stated, Yes, he keeps the
Ozempic and a bottle of Genvoya medications at the bedside, but it is a nurse that administers the
medications to him.
During an observation and interview on September 11, 2024, at 9:55 AM, with the Director of Nursing
(DON), the DON was asked if Resident 3 kept his medications by the bedside. The DON stated, Yes, we
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
056024
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056024
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/26/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Palms Healthcare Center
7534 Palm Ave
Highland, CA 92346
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
let him keep the Ozempic and Genvoya medications at the bedside, so he does not assume the
medications are not available.
During a review of Resident 3 ' s Order Summary Report included, Genvoya (medication used to treat HIV
infection) tablet 150-200-10 milligram . Give 1 tablet by mouth one time a day for retroviral (medication that
treats infection).
During a review of Resident 3 ' s care plan dated December 23, 2021, indicated, Focus: HIV and AIDS
(acquired immunodeficiency syndrome (a disease caused by HIV) at risk for complications manifested by
decreased white blood cells count, fatigue, fluid volume deficit, imbalanced . Goal: will have minimal
complications related to extent possible . Interventions: Administer medication as ordered .
During a review of Resident 3 ' s Order Summary Report included, Ozempic (medication used to treat
diabetes mellitus (0.25 or 0.5 milligram/dose [a unit of measurement) subcutaneous solution pen-injector
(injection given in the tissue just under skin) 2 milligrams . inject 1 milligram subcutaneously one time a day
every Wednesday for diabetes mellitus.
During a review of Resident 3 ' s care plan dated September 9, 2024, indicated, Focus: .Resident requires
Ozempic medication related to diabetes. Goal: Will exhibit a therapeutic effect related to the use of the
medication. Interventions: Administer medication as ordered .
During a concurrent interview and record review on September 11, 2024, at 11:25 PM, with the DON, the
facility ' s policy and procedure (P&P), titled, Storage of Medications dated, November 2020, was reviewed.
The P&P indicated, .The facility stores all drugs and biologicals in a safe, secure, and orderly manner.
Policy Interpretation and Implementation 1. Drugs and biologicals used in the facility are stored in locked
compartments under proper temperature, light and humidity controls. Only persons authorized to prepare
and administer medications have access to locked medications . 3. The nursing staff is responsible for
maintaining medication storage and preparation areas in a clean, safe, and sanitary manner . The DON
stated, We did not follow the facility policy and procedure, the medications should have been stored in a
locked compartment under proper temperature.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056024
If continuation sheet
Page 2 of 2